PATENT CLAIM ANALYSIS

Application Number: 15758045
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "229800"]

Abstract:
A genus of arylsulfonamide derivatives of heterocyclic constrained tricyclic compounds is disclosed. The compounds are of the following genus: The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a therapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.

Claim (Index 27):
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound according to  claim 1 .

Metadata:
- Claim Count in Document: 46.0
- Percentile: 90.0
- Lexical Diversity: 1.42105
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15758038', '15124891', '15750388', '12041860', '11862690']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.787988425905264
- 35 USC 102 Novelty (BERT): 0.5527100845961576
- Combined Prediction Score: 0.7644605917743533
- Mean Citation Score: 340.52525
- Max Citation Score: 418.73618
- Similarity Product: 370.96665179133765

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test